{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04731",
    "Peptide Name": "TC-14 (TC-33 analog, synthetic AMPs, Lys-rich, XXA, UCLL1c)",
    "Source": "sequence truncation, mammal cathelicidin analog, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "KIGQKIKNFFRKLL",
    "Sequence Length": 14,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Helix",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 1.62,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "43%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (63.16%) toCRAMP-18K: 29%, I=L=F: 14%.Activity: Active against E. coli ATCC8739 (MIC 9.38 ug/ml), A. baumannii ATCC19606 (MIC 2.34 ug/ml), P. aeruginosa ATCC27853 (MIC 9.38 ug/ml), and S. aureus ATCC6538 (MIC 4.68 ug/ml).Structure: random coil in water and helical in 8 mM SDS micelles (74%).In vitro toxicity: human RBC: no hemolysis at 100 ug/ml, not hemo.lytic. Not toxic to HaCaT cells at 100 ug/ml.MOA:bacteria: permeabilized membranes of E. coli, A. baumannii, S. aureus, P. aeruginosa.Resistance development:no:bacteria:P. aeruginosa 27853: P. aeruginosa 27853 and Resistance development:no:bacteria:S. aureus 6538 did not become resistant after 60 passages (generations), but control colistin or vancomycin did.In vivo toxiity: IV injection to mice at 10 mg/kg did not lead to observable toxicity.Animal model:mouse: it could reduce S. aureus or A. baumannii burden dose-dependently in a murine skin wound model.Updated 12/2024",
    "Author": "Chenxi Li, Ying Cai, Lin Luo, Gengzhou Tian, Xingyu Wang, An Yan, Liunan Wang, Sijing Wu, Zhongxiang Wu, Tianyu Zhang, Wenlin Chen, Zhiye Zhang, 2024",
    "Reference": "iScience. 2024 Jun 28;27(7):110404. doi: 10.1016/j.isci.2024.110404.SciDirect",
    "Title": "TC-14, a cathelicidin-derived antimicrobial peptide with broad-spectrum antibacterial activity and high safety profile"
  },
  "3D Structure": []
}